For: | Solé S, Becerra S, Carvajal C, Bettolli P, Letelier H, Santini A, Vargas L, Cifuentes A, Larsen F, Jara N, Oyarzún J, Bustamante E, Martínez B, Rosenberg D, Galván T. Clinical relevance of the use of Dentoxol® for oral mucositis induced by radiotherapy: A phase II clinical trial. World J Clin Oncol 2022; 13(10): 813-821 [PMID: 36337310 DOI: 10.5306/wjco.v13.i10.813] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v13/i10/813.htm |
Number | Citing Articles |
1 |
Margherita Gobbo, Jamie Joy, Helena Guedes, Muhammad Ali Shazib, Carryn Anderson, Ragda Abdalla-Aslan, Khunthong Peechatanan, Carlo Lajolo, Khawaja Shehryar Nasir, Luiz Alcino Gueiros, Nivethitha Nagarajan, Kimia Hafezi Motlagh, Abhishek Kandwal, Cosimo Rupe, Yuanming Xu, Eli D. Ehrenpreis, Arghavan Tonkaboni, Joel B. Epstein, Paolo Bossi, Hannah R. Wardill, Stephanie L. Graff. Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents. Expert Opinion on Pharmacotherapy 2024; 25(6): 727 doi: 10.1080/14656566.2024.2354451
|
2 |
Rui Vitorino. Translational mapping of mechanistic and biomarker‐driven clinical trials in oral squamous cell carcinoma and oral potentially malignant disorders. Annals of the New York Academy of Sciences 2025; doi: 10.1111/nyas.15405
|
3 |
Paola Rojas, Susanne Krämer, Sebastián Véliz, Melissa Seguel, Fatimah Alsayer, Lorena Sepúlveda. Dentoxol Mouthwash for People With Epidermolysis Bullosa: A Qualitative Study of Self‐Perceived Symptoms and Quality of Life. Special Care in Dentistry 2025; 45(2) doi: 10.1111/scd.70036
|